You are viewing the site in preview mode
Skip to main content
| |
Group A (n = 25)
|
Group B (n = 28)
|
Group C (n = 26)
|
P
|
|---|
|
Intraoperative adverse reactions, n (%)
|
|
SpO2 < 90 %
|
2 (8.0)
|
1 (3.6)
|
1 (3.8)
|
0.685
|
|
PETCO2>45 mmHg
|
1 (4.0)
|
5 (17.9)
|
5 (19.2)
|
0.213
|
|
SBP < 90mmHg
|
8 (32.0)
|
11 (39.3)
|
19 (73.1)ab
|
0.007
|
|
Arrhythmia
|
2 (8.0)
|
5 (17.9)
|
4 (15.4)
|
0.609
|
|
Postoperative pulmonary complications, n (%)
|
|
Total
|
21 (84.0)
|
16 (57.1)a
|
14 (53.8)a
|
0.047
|
|
Hypoxemia
|
13 (52.0)
|
4 (14.3)a
|
5 (19.2)a
|
0.005
|
|
Pulmonary infection
|
21 (84.0)
|
14 (50.0)a
|
11 (42.3)a
|
0.006
|
|
Atelectasis
|
6 (24.0)
|
1 (3.6)a
|
0 (0.0)a
|
0.004
|
|
Acute respiratory distress syndrome
|
1 (4.0)
|
1 (3.6)
|
0 (0.0)
|
0.764
|
|
Ventilator-associated lung injury
|
3 (12.0)
|
3 (10.7)
|
2 (7.7)
|
0.902
|
|
Neurogenic pulmonary edema
|
1 (4.0)
|
0 (0.0)
|
1 (3.9)
|
0.537
|
|
Postoperative neurological complications, n (%)
|
|
Intracranial infection
|
3 (12.0)
|
3 (10.7)
|
4 (15.4)
|
0.915
|
|
Intracranial hypertension
|
6 (24.0)
|
7 (25.0)
|
7 (26.9)
|
1.000
|
|
Epilepsy
|
2 (8.0)
|
2 (7.1)
|
3 (11.5)
|
0.890
|
|
Encephaledema
|
5 (20.0)
|
5 (17.9)
|
6 (23.1)
|
0.939
|
|
Reoperation
|
2 (8.0)
|
1 (3.6)
|
2 (7.7)
|
0.733
|
|
Other
|
|
Mechanical ventilation time, h, median (interquartile range)
|
72.0 (36.0-105.0)
|
24.0 (3.0–62.0)a
|
24.0 (9.1–66.0)a
|
0.006
|
|
Length of stay, days, mean ± SD
|
21.5 ± 10.4
|
21.9 ± 8.3
|
22.0 ± 7.5
|
0.975
|
|
GOSE score, mean ± SDc
|
5 ± 1.6
|
6 ± 1.3
|
5 ± 1.2
|
0.768
|
- GOSE Glasgow Outcome Scale Extended; PETCO2 end-tidal carbon dioxide partial pressure; SBP systolic blood pressure; SD standard deviation; SpO2 oxygen saturation
- aP<0.05 compared to Group A; bP<0.05 compared to Group B
- c GOSE is used to assess outcomes of patients with brain damage and is divided into 8 levels. The higher the grade, the better the patient’s prognosis is
